Publicacións nas que colabora con Vicenta Martínez Zorzano (31)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

2015

  1. Aplicación de la proteómica en la búsqueda de nuevos marcadores tumorales para el cáncer colorrectal

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 533-547

  2. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening

    Scientific Reports, Vol. 5

  3. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381

2014

  1. Proteomics for discovery of candidate colorectal cancer biomarkers

    World Journal of Gastroenterology, Vol. 20, Núm. 14, pp. 3804-3824

2013

  1. Decreased expression of alpha-L-fucosidase gene FUCA1 in human colorectal tumors

    International Journal of Molecular Sciences, Vol. 14, Núm. 8, pp. 16986-16998

2012

  1. Changes on the Caco-2 secretome through differentiation analyzed by 2-D differential in-gel electrophoresis (DIGE)

    International Journal of Molecular Sciences, Vol. 13, Núm. 11, pp. 14401-14420

  2. Magnetic silica nanoparticle cellular uptake and cytotoxicity regulated by electrostatic polyelectrolytes-DNA loading at their surface

    ACS Nano, Vol. 6, Núm. 1, pp. 747-759

2011

  1. Protein isoforms and their special role as cancer biomarkers

    Cancer Biomarkers (Nova Science Publishers, Inc.), pp. 105-137

  2. Selection of putative colorectal cancer markers by applying PCA on the soluble proteome of tumors: NDK A as a promising candidate

    Journal of Proteomics, Vol. 74, Núm. 6, pp. 874-886

2009

  1. In the search of early stages biomarkers for non small cell lung cancer

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 155-155

  2. Nucleoside diphosphate kinase A (NM23-H1) as a potential biomarker candidate for colorectal cancer

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 122-122

2008

  1. Cytotoxicity of selected imidazolium-derived ionic liquids in the human Caco-2 cell line. Sub-structural toxicological interpretation through a QSAR study

    Green Chemistry, Vol. 10, Núm. 5, pp. 508-51

2007

  1. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer

    International Journal of Biochemistry and Cell Biology, Vol. 39, Núm. 3, pp. 529-540

  2. Relevance of protein isoforms in proteomic studies

    Current Proteomics, Vol. 4, Núm. 4, pp. 235-252

2004

  1. Clinical significance of preoperative serum sialic acid levels in colorectal cancer: Utility in the detection of patients at high risk of tumor recurrence

    International Journal of Biological Markers, Vol. 19, Núm. 1, pp. 38-45

2003

  1. Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma

    Oncology Reports, Vol. 10, Núm. 5, pp. 1345-1350

  2. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer

    Oncology, Vol. 64, Núm. 1, pp. 36-45